Baxter, the US pharmaceuticals company, has failed to meet its pledge to rapidly deliver flu vaccine, stalling efforts to reduce the impact of the pandemic.

British officials said they had received less Celvapan vaccine than agreed with Baxter, one of two companies with which the Department of Health signed a contract this year.